CATX — Perspective Therapeutics Inc.

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates CATX Bearish with a Setup Score of 44, net conviction 47, actionability 42. How the Setup Score works →

Total Setup Score44
Directional BiasBearish
Net Conviction47
Actionability42 (in range)

Key signals behind this score

About Perspective Therapeutics Inc.

Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted r… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$2.66
Market Cap$309M
Float70.8M
Shares Outstanding114.2M
P/E (Forward)25.71
Price/Sales (TTM)756.36
vs. Analyst Target+361.9% to analyst PT
Operating Margin (TTM)-36120.99%
Revenue (TTM)$409,000
Dividend RateNone
Analyst Target Price$12.29 (14 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2022 $10.8M -$7.2M $4.6M -$7.1M
2022 $7.1M -$14.7M $1.6M -$14.8M
2023 $7.1M -$14.7M $1.6M -$14.8M
2023 $1.4M -$46.5M $1.4M -$40.0M
2024 $1.5M -$79.3M -$852,000 $10.5M
2025 $884,000 -$103M -$2.4M -$101M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 $209,000 -$26.0M
Dec 2025 $43,000 -$37.5M
Mar 2026 $76,000 -$26.2M
Jun 2026 $81,000 -$26.8M

Ownership & Float

Insider Ownership8.2%
Institutional Ownership86.0%
Short Float33.0%
% of All Funds Holding1.46%
Number of Funds Holding128

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$2.94Near-term / short-term trend
Weekly40-Week SMA$3.61Medium-term trend
Weekly80-Week SMA$3.34Cyclical trend (business cycle)
Weekly200-Week SMA$5.62Secular trend (multi-year)
Monthly10-Month SMA$3.61Near-term monthly trend
Monthly20-Month SMA$3.26Medium-term monthly trend
Monthly40-Month SMA$5.62Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$11.90 resistance 2.64x 22 months ago

Historical Earnings Reactions (78 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -1.20% 0.00% 38.46% 21.79% -28.57%
1 Day -1.69% -0.70% 35.90% 25.00% -26.67%
1 Week -0.49% -2.70% 41.03% 109.52% -42.17%
2 Weeks 0.87% -5.19% 39.74% 107.14% -61.39%
1 Month 3.44% -2.92% 42.31% 250.72% -67.39%

Next earnings: November 9, 2026 (30 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan29.2%61.9%21
Feb-3.4%33.3%21
Mar7.4%42.9%21
Apr9.6%57.1%21
May1.9%42.9%21
Jun-2.5%33.3%21
Jul6.0%42.9%21
Aug5.4%38.1%21
Sep-9.8%23.8%21
Oct-7.3%25.0%20
Nov-1.9%30.0%20
Dec-3.5%38.1%21

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.11% 34.1% 985
Tuesday -0.12% 35.8% 1079
Wednesday 0.86% 39.9% 1079
Thursday 0.01% 39.6% 1058
Friday 0.30% 39.7% 1054

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 86.0%

Insider Transactions — Smart Summary

Total insider ownership: 8.2%

12-Month Insider Activity Summary

Total Filings6
Net Value+$22,294.8
Net Shares Change-497,391
% of Float-0.7%
C-Suite Filings1
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Lantheus Alpha Therapy, LLC -$1.3M 2 2 sell
Lantheus Holdings, Inc. -$357,183.977 2 2 sell
Hunt Jonathan Robert Chief Accounting Officer +$22,294.8 1 1 buy
Williamson Robert F III +$19,945.8 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-09-08 Lantheus Alpha Therapy, LLC -$776,944.508 Transaction at $3.13, now -15.1%
2025-11-17 Hunt Jonathan Robert Chief Accounting Officer +$22,294.8 Transaction at $2.03, now +31.2%
2026-09-04 Lantheus Alpha Therapy, LLC -$488,398.986 Transaction at $3.13, now -15.0%
2026-09-03 Lantheus Holdings, Inc. -$111,574.242 Transaction at $3.12, now -14.7%
2026-09-02 Lantheus Holdings, Inc. -$245,609.735 Transaction at $3.14, now -15.4%
2025-11-14 Williamson Robert F III +$19,945.8 Transaction at $2.10, now +26.7%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Perspective Therapeutics Inc. (CATX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for CATX on Trend Edge →